PDZK1IP1, PDZK1 interacting protein 1, 10158

N. diseases: 46; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE MAP17 is a small, 17-kDa, non-glycosylated membrane protein that is overexpressed in a percentage of carcinomas. 22266858 2012
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE We identified MAP17, a small 17 kDa non-glycosylated membrane protein previously identified by differential display being over-expressed in carcinomas. 17548903 2007
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE MAP17 (PDZK1IP1) is a small, 17 kDa non-glycosylated membrane protein located in the plasma membrane and Golgi apparatus and is overexpressed in a wide variety of human carcinomas. 30250642 2018
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE Taken together, our data show an independent activation of MAP17 promoter that can be driven by oncogenes and that might explain the common overexpression of MAP17 in human carcinomas. 17426052 2007
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE In addition, DD96 is overexpressed markedly in various human carcinomas originating from the colon, breast, and lung, as well as in a number of cell lines derived from tumors of these organs compared with normal epithelial cell populations. 9815914 1995
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE MAP17 is a small nonglycosylated membrane protein that is overexpressed in a high percentage of carcinomas. 25837675 2015
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.070 AlteredExpression group BEFREE Using in situ hybridization, we demonstrated that MAP17 and PDZK1 mRNAs are markedly up-regulated in human carcinomas. 10496535 1999